Live tape
Top 8, mentions 7d7,144NVDA1,224 mentions▲ +0.10GOOGL1,061 mentions▲ +0.04AVGO1,017 mentions▲ +0.05NKE1,002 mentions+0.02LULU948 mentions▲ +0.03TSLA823 mentions▲ +0.06META571 mentions▲ +0.06MSFT498 mentions▲ +0.07

Equity · Healthcare

BWAY

BrainsWay Ltd. · NasdaqGM

$14.23 −2.40% 1D Finazon · prior-day close · Sep 4, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$17 $13 10 Jun 4 Sep

The line runs $14.22 on 10 June through $14.23 on 4 September, on a scale from $13 to $17. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of BWAY over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $14.22 on 10 June 2026 through $14.23 on 4 September 2026.

52-week range $7.33 – $17
Avg volume 9.8K

Finazon · prior-day close · as of Sep 8, 2026

Filings 2 sets

BWAY institutional holders

SEC Form 13F

5 of the 45 institutional funds we track reported a BWAY position for the quarter ended 30 Jun 2026 — a combined $12.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −8.2% shares 475,920 $7.4M
ARK Investment Management Trimmed −26.4% shares 142,500 $2.2M
Two Sigma Investments Held (±25%) −22.3% shares 99,545 $1.5M
Citadel Advisors Trimmed −45.4% shares 47,519 $737K
Man Group Held (±25%) +0.9% shares 27,474 $426K

Source: SEC EDGAR 13F filings

BWAY fails-to-deliver

SEC CNS data

On 05 Aug 2026, 3 shares of BWAY failed to deliver (about $47).

Settlement date Shares failed Notional % of shares out
05 Aug 2026 3 $47 <0.001%
03 Aug 2026 30 $457 <0.001%

Source: SEC fails-to-deliver (CNS) data